Discontinuation of benzodiazepines and related medicinal products: procedure for the doctor providing outpatient treatment
Practice guidelines - Posted on Jun 29 2015
The aim is to reduce the long-term prescription of benzodiazepines (BZD) and related medicinal products for anxiety disorders and insomnia because the benefit-risk relationship is unfavourable.
Despite prescriptions being of limited duration, it has been observed that usage may extend over several months, or even several years. However, beyond a few weeks, the risks of adverse effects increase: daytime drowsiness, falls, accidents, memory impairment, etc., as also does the risk of dependence.
HAS opinions and decisions